Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Glucose-dependent Insulinotropic Polypeptide: Blood Glucose Stabilizing Effects in Patients with Type 2 diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Genetic variation at PPP1R3B increases hepatic CT attenuation and interacts with prandial status on plasma glucose

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Heterozygous Mutation (Q459R) in the Calcium-Sensing Receptor Gene Causes Familial Hypocalciuric Hypercalcemia 1 (FHH1)

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Increases in bioactive IGF do not parallel increases in total IGF-I during growth hormone treatment of children born SGA

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Muscle-liver substrate fluxes in exercising humans and potential effects on hepatic metabolism

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Glycemic control and use of glucose-lowering medications in hospital-admitted type 2 diabetes patients over 80 years

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Effects of Gender-Affirming Hormone Therapy on Insulin Sensitivity and Incretin Responses in Transgender People

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Context. Patients with type 2 diabetes mellitus (T2DM) have clinically relevant disturbances in the effects of the hormone glucose-dependent insulinotropic polypeptide (GIP). Objective. To evaluate the importance of the prevailing plasma glucose levels for the effect of GIP on responses of glucagon and insulin and glucose disposal in patients with T2DM. Design. A placebo-controlled, cross-over, experimental study. Settings. Copenhagen University hospital Gentofte. Patients. Twelve patients with T2DM (age: 62±1 years (mean±SEM), BMI: 29±1 kg/m(2); HbA1c: 6.5±0.1% (48±2 mmol/mol)). Intervention. Iv infusions of physiological amounts of GIP (2 pmol×kg(-1)×min(-1)) or saline. Main Outcome Measures. Plasma concentrations of glucagon, glucose, insulin, C-peptide, intact GIP and amounts of glucose needed to maintain glucose clamps. Results. During fasting glycemia (plasma glucose ∼8 mmol/l), GIP elicited significant increments in both insulin and glucagon levels resulting in neutral effects on plasma glucose. During insulin-induced hypoglycemia (plasma glucose ∼3 mmol/l), GIP elicited a minor early-phase insulin response and increased glucagon levels during the initial 30 minutes resulting in less glucose needed to be infused to maintain the clamp (29±8 vs. 49±12 mg×kg(-1), p
Original languageEnglish
JournalThe Journal of clinical endocrinology and metabolism
Pages (from-to)jc20133644
ISSN0021-972X
DOIs
Publication statusPublished - 10 Dec 2013

ID: 42438283